Receptor-dependent targeting of lipoproteins to specific cell types of the liver.
Van Berkel
T J
TJ
Leiden University, The Netherlands.
Kruijt
J K
JK
De Smidt
P C
PC
Bijsterbosch
M K
MK
D000818:Animals; D037263:Asialoglycoprotein Receptor; D001212:Asialoglycoproteins / Q000378:metabolism; D002788:Cholesterol Esters / Q000378:metabolism; D002914:Chylomicrons / Q000378:metabolism; D060748:Fetuins; D008074:Lipoproteins / Q000008:administration & dosage*; D008075:Lipoproteins, HDL / Q000378:metabolism; D008079:Lipoproteins, VLDL / Q000378:metabolism; D008099:Liver / Q000166:cytology / Q000378:metabolism*; D051381:Rats; D011971:Receptors, Immunologic / Q000378:metabolism*; D000509:alpha-Fetoproteins / Q000378:metabolism
D037263:Asialoglycoprotein Receptor; D001212:Asialoglycoproteins; D002788:Cholesterol Esters; D002914:Chylomicrons; D060748:Fetuins; D008074:Lipoproteins; D008075:Lipoproteins, HDL; D008079:Lipoproteins, VLDL; D011971:Receptors, Immunologic; D000509:alpha-Fetoproteins; C017029:asialofetuin; C042924:N-(tris((beta-galactopyranosyloxy)methyl)methyl)-N(alpha)-(4-(5-cholesten-3 beta-yloxy)succinyl)glycinamide